Stock LAURUSLABS LAURUS LABS LIMITED
Add to a list
To use this feature you must be a member
Log inSign up

News Laurus Labs Limited

Equities

LAURUSLABS

INE947Q01028

Market Closed - NSE India S.E.
Other stock markets
 07:43:52 2024-05-15 EDT 		5-day change 1st Jan Change
437.4 INR +0.84% Intraday chart for Laurus Labs Limited +0.77% +1.69%
05-15 Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion RE
04-25 Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024

Summary

Search
See the results
Unlock all the news on all businesses: Never miss an investment opportunity again!
100% Free Registration
Granules India posts Q4 revenue fall on weak paracetamol sales, price erosion
RE
Transcript : Laurus Labs Limited, Q4 2024 Earnings Call, Apr 25, 2024
Laurus Labs' Consolidated Profit Falls in Fiscal Q4
MT
Laurus Labs Limited Approves Second Interim Dividend for the Financial Year 2023-2024, Payable on or After May 17, 2024
CI
Laurus Labs Limited Approves Board Changes
CI
Laurus Labs Limited Reports Earnings Results for the Full Year Ended March 31, 2024
CI
Laurus Labs Limited Reports Earnings Results for the Fourth Quarter Ended March 31, 2024
CI
Laurus Labs Board to Consider Second Interim Dividend for Fiscal Year 2024
MT
Laurus Labs Incorporates New JV Company with Slovenia-Based Pharmaceutical Company
MT
Laurus Labs, Slovenia's Krka to Form JV; Laurus Shares Fall 6%
MT
Laurus Labs Limited Reaches to Agreement with Krka to Establish Joint Venture Company in Hyderabad, India Namely Krka Pharma Pvt. Ltd
CI
Jefferies Adjusts Laurus Labs’ Price Target to INR250 From INR290, Keeps at Underperform
MT
Laurus Labs Limited Reports Earnings Results for the Third Quarter and Nine Months Ended December 31, 2023
CI
Transcript : Laurus Labs Limited, Q3 2024 Earnings Call, Jan 24, 2024
INDIA STOCKS-IT drives losses in Indian shares ahead of Fed policy outcome
RE
Indian shares set to open higher; focus turns to Fed policy
RE
Laurus Labs Completes Acquisition of Additional Stake in Laurus Bio
MT
Laurus Labs Limited completed the acquisition of additional 14.54% stake in Laurus Bio Private Limited from one of the Promoters, non-executive director, his family members and few Employee/ex-Employee shareholders.
CI
Jefferies Adjusts Laurus Labs’ Price Target to INR260 From INR250, Keeps at Underperform
MT
Laurus Labs Limited Announces Resignation of Chandrakanth Chereddi as Non-Executive Director
CI
No results for this search
All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Filters

Search

Announcement Date

Since

Until

  1. Stock Market
  2. Equities
  3. LAURUSLABS Stock
  4. News Laurus Labs Limited
-40% Limited Time Offer: Our subscriptions help you unlock hidden opportunities.
BENEFIT NOW